Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

JPMorgan’s net income soared 50% to more than $14 billion in the fourth quarter as the bank’s profit and revenue easily beat ...

GoodRx CEO Wendy Barnes outlined the company's priorities at the 2025 JP Morgan Healthcare Conference in San Francisco.

In a report released today, John McDonald CFA from Truist Financial assigned a Hold rating to JPMorgan Chase & Co. (JPM – Research Report).

In a report released today, Glenn Schorr from Evercore ISI maintained a Buy rating on JPMorgan Chase & Co. (JPM – Research Report), with a ...

UBS increased their price target for JPMorgan shares, listed on the New York Stock Exchange (NYSE:JPM), to $287 from the ...

Analysis of JPMorgan Chase and Goldman Sachs Q4 2024 earnings forecasts, including key metrics, analyst expectations and ...

Teladoc Health faces pressure in a saturated telehealth market, but it's hard to ignore the virtual care company's massive ...

It's not just JPMorgan Chase. Across the industry, banks are rethinking their remote-work policies — but experts say it won't ...

Spain’s Almirall has announced strategic plans at the 43rd JP Morgan Healthcare Conference based on expected double-digit growth within the dermatological area for Almirall’s psoriasis and atopic ...

Almirall, a global pharmaceutical company dedicated to medical dermatology, is participating in the 2025 JPMorgan HealthCare ...